• Explore /
  • Poster
  • / Neoadjuvant chemotherapy with atezolizumab, bevacizumab, and FOLFOX for patients with unresectable colorectal liver metastases: A translational pilot study.

Neoadjuvant chemotherapy with atezolizumab, bevacizumab, and FOLFOX for patients with unresectable colorectal liver metastases: A translational pilot study.

Abstract Poster

Authors

null

Sun Young Kim

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Sun Young Kim , Wonkyung Kim , Chang Ohk Sung , Jihun Kim , Yong Sang Hong , Jeong Eun Kim , Tae Won Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

03698461

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3573)

DOI

10.1200/JCO.2024.42.16_suppl.3573

Abstract #

3573

Poster Bd #

236

Abstract Disclosures

Similar Posters

First Author: Eugenia Li Ling Yeo

First Author: Claudia A.M. Fulgenzi

First Author: Jennifer F. De Los Santos

First Author: Claire Gallois